$20.50
In chiusura: Oct 1 EDT
$20.50
0.000.00%
Pre-mercato: 4:01 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Seres Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 12
Stima EPS
$0.780
Stima dei ricavi trimestrali
$5.88M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
–
Analizza lo storico degli utili di Seres Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
MCRB | Seres Therapeutics | -$6.60 | $0.78 | — | — | $0.00 | $5.88M | — | — | 11/12/2025 | |
MCRB | Seres Therapeutics | -$4.34 | -$2.45 | -$2.27 | 7.35% | $0.00 | — | $0.00 | — | 08/06/2025 | |
MCRB | Seres Therapeutics | -$5.40 | $1.60 | $3.75 | 134.38% | $0.00 | $16.67M | $0.00 | -100.00% | 05/07/2025 | |
MCRB | Seres Therapeutics | -$6.40 | -$4.00 | -$1.60 | 60.00% | $64.00K | — | $0.00 | — | 03/13/2025 | |
MCRB | Seres Therapeutics | -$7.40 | -$4.80 | -$6.60 | -37.50% | $310.00K | — | $0.00 | — | 11/13/2024 | |
MCRB | Seres Therapeutics | $7.20 | -$5.40 | -$4.40 | 18.52% | $126.47M | — | $0.00 | — | 08/13/2024 | |
MCRB | Seres Therapeutics | -$11.40 | -$6.80 | -$5.40 | 20.59% | -$522.00K | $250.00K | $0.00 | -100.00% | 05/08/2024 | |
MCRB | Seres Therapeutics | -$10.80 | -$10.00 | -$6.40 | 36.00% | $975.00K | — | $64.00K | — | 03/05/2024 | |
MCRB | Seres Therapeutics | -$9.80 | -$10.00 | -$7.40 | 26.00% | $3.44M | $1.87M | $310.00K | -83.42% | 11/02/2023 | |
MCRB | Seres Therapeutics | -$14.00 | $11.00 | $7.20 | -34.55% | $1.22M | $125.50M | $126.47M | 0.78% | 08/08/2023 | |
MCRB | Seres Therapeutics | -$12.20 | -$11.00 | -$11.40 | -3.64% | $1.49M | $1.38M | -$522.00K | -137.83% | 05/09/2023 | |
MCRB | Seres Therapeutics | -$11.00 | -$9.20 | -$10.80 | -17.39% | $7.22M | — | $975.00K | — | 03/07/2023 | |
MCRB | Seres Therapeutics | $14.40 | -$9.40 | -$9.80 | -4.26% | $126.72M | $7.00M | $3.44M | -50.80% | 11/02/2022 | |
MCRB | Seres Therapeutics | -$10.60 | -$12.00 | -$14.00 | -16.67% | $5.26M | — | $1.22M | — | 08/03/2022 | |
MCRB | Seres Therapeutics | -$7.80 | -$10.40 | -$12.20 | -17.31% | $5.72M | — | $1.49M | — | 05/04/2022 | |
MCRB | Seres Therapeutics | -$3.80 | -$8.80 | -$11.00 | -25.00% | $17.56M | $12.25M | $7.22M | -41.05% | 03/01/2022 | |
MCRB | Seres Therapeutics | -$7.20 | -$9.20 | $14.40 | 256.52% | $1.42M | $7.32M | $126.72M | 1631.22% | 11/10/2021 | |
MCRB | Seres Therapeutics | -$5.60 | -$7.40 | -$10.60 | -43.24% | $6.04M | $5.34M | $5.26M | -1.44% | 08/03/2021 | |
MCRB | Seres Therapeutics | -$5.60 | -$6.20 | -$7.80 | -25.81% | $8.19M | $6.45M | $5.72M | -11.35% | 05/04/2021 | |
MCRB | Seres Therapeutics | -$5.00 | -$5.60 | -$3.80 | 32.14% | $7.62M | $6.93M | $17.56M | 153.45% | 03/02/2021 | |
MCRB | Seres Therapeutics | -$4.60 | -$5.00 | -$7.20 | -44.00% | $7.03M | — | $1.42M | — | 11/09/2020 |
Seres Therapeutics (MCRB) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $-2.27 | $-2.45 | 7.35 % |
| Q1 | 2025-05-07 | $3.75 | $1.60 | 134.4 % |
| Q4 | 2025-03-13 | $-1.60 | $-4.00 | 60.0 % |
| Q3 | 2024-11-13 | $-6.60 | $-4.80 | -37.5 % |
Seres Therapeutics (MCRB) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q1 | 2025-05-07 | $0 | $16.67M | -100.0 % |
| Q1 | 2024-05-08 | $0 | $250.00K | -100.0 % |
| Q3 | 2023-11-02 | $310.00K | $1.87M | -83.4 % |
| Q2 | 2023-08-08 | $126.47M | $125.50M | 0.78 % |
FAQ
Quando Seres Therapeutics (NASDAQ:MCRB) riporterà gli utili?
Si prevede che Seres Therapeutics (MCRB) fornisca risultati il novembre 12, 2025. Gli ultimi risultati sono stati pubblicati il agosto 6, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Seres Therapeutics (NASDAQ:MCRB)?
L'EPS effettivo era $-2.27, che superato la stima di $-2.45.
Quali sono state le entrate di Seres Therapeutics (NASDAQ:MCRB)?
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.